189
Participants
Start Date
July 31, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
March 31, 2015
pazopanib (GW786034) 400 mg
400 mg administered orally once daily
lapatinib (GW572016) 1500 mg
1500 mg administered orally once daily.
lapatinib (GW572016) 1000 mg
1000 mg administered orally once daily
pazopanib (GW786034) 800 mg
800 mg administered orally once daily
GSK Investigational Site, Budapest
GSK Investigational Site, Budapest
GSK Investigational Site, Islamabad
GSK Investigational Site, Bangkok
GSK Investigational Site, The Bronx
GSK Investigational Site, Marseille Cedex BP 156
GSK Investigational Site, Besançon
GSK Investigational Site, Haifa
GSK Investigational Site, Akron
GSK Investigational Site, Indianapolis
GSK Investigational Site, Petaling Jaya
GSK Investigational Site, Petah Tikva
GSK Investigational Site, Ramat Gan
GSK Investigational Site, Lahore
GSK Investigational Site, Lahore
GSK Investigational Site, Lille
GSK Investigational Site, Bandar Tun Razak, Cheras
GSK Investigational Site, Multan
GSK Investigational Site, Tel Aviv
GSK Investigational Site, Strasbourg
GSK Investigational Site, Lyon
GSK Investigational Site, Metairie
GSK Investigational Site, Jonesboro
GSK Investigational Site, Karachi
GSK Investigational Site, Paris
GSK Investigational Site, Rehovot
GSK Investigational Site, San Antonio
GSK Investigational Site, Lubbock
GSK Investigational Site, Hyères
GSK Investigational Site, Henderson
GSK Investigational Site, Redondo Beach
GSK Investigational Site, Long Beach
GSK Investigational Site, Jerusalem
GSK Investigational Site, Northridge
GSK Investigational Site, Alhambra
GSK Investigational Site, Fullerton
GSK Investigational Site, Oxnard
GSK Investigational Site, Santa Barbara
GSK Investigational Site, Bakersfield
GSK Investigational Site, Santa Maria
GSK Investigational Site, Mérida
GSK Investigational Site, Delhi
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Singapore
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Jaipur
GSK Investigational Site, Mumbai
GSK Investigational Site, Pune
GSK Investigational Site, Bangalore
GSK Investigational Site, Trivandrum
GSK Investigational Site, Los Angeles
GSK Investigational Site, Dallas
GSK Investigational Site, Edmonton
GSK Investigational Site, Halifax
GSK Investigational Site, Weston
GSK Investigational Site, Győr
GSK Investigational Site, Pune
GSK Investigational Site, Mexico City
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Callao
GSK Investigational Site, Elblag
GSK Investigational Site, Kielce
GSK Investigational Site, Krakow
GSK Investigational Site, Olsztyn
GSK Investigational Site, Olsztyn
GSK Investigational Site, Warsaw
GSK Investigational Site, Moscow
GSK Investigational Site, Incheon
GSK Investigational Site, Seodaemun-gu, Seoul
GSK Investigational Site, Songpa-gu, Seoul
GSK Investigational Site, Suwon, Kyonggi-do
GSK Investigational Site, Chelmsford
GSK Investigational Site, Manchester
GSK Investigational Site, Sutton
GSK Investigational Site, Birmingham
GSK Investigational Site, Glasgow
GSK Investigational Site, Ipswich
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Nottingham
GSK Investigational Site, Plymouth
Lead Sponsor
GlaxoSmithKline
INDUSTRY